NO20001687L - Benzamidinderivater som faktor Xa-inhibitorer - Google Patents

Benzamidinderivater som faktor Xa-inhibitorer

Info

Publication number: NO20001687L
Authority: NO; Norway
Prior art keywords: formula; piperazine; methyl; phenyl; fab
Prior art date: 1997-10-01

Application number

NO20001687A

Other languages

English (en)

Norwegian (no)

Other versions

NO20001687D0 (no

Inventor

Dieter Dorsch

Horst Juraszyk

Hanns Wurziger

Sabine Bernotat-Danielowski

Guido Melzer

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-01

Filing date

2000-03-31

Publication date

2000-03-31

2000-03-31 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2000-03-31 Publication of NO20001687D0 publication Critical patent/NO20001687D0/no

2000-03-31 Publication of NO20001687L publication Critical patent/NO20001687L/no

Links

229940123583 Factor Xa inhibitor Drugs 0.000 title 1
150000003937 benzamidines Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 claims description 108
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 35
150000003839 salts Chemical class 0.000 claims description 25
125000006239 protecting group Chemical group 0.000 claims description 20
239000000460 chlorine Substances 0.000 claims description 19
229910052731 fluorine Inorganic materials 0.000 claims description 19
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 19
229910052801 chlorine Inorganic materials 0.000 claims description 18
125000001624 naphthyl group Chemical group 0.000 claims description 18
229910052794 bromium Inorganic materials 0.000 claims description 17
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
125000004432 carbon atom Chemical group C* 0.000 claims description 15
238000000034 method Methods 0.000 claims description 15
239000002253 acid Substances 0.000 claims description 14
229910052740 iodine Inorganic materials 0.000 claims description 14
238000002360 preparation method Methods 0.000 claims description 14
229910052757 nitrogen Inorganic materials 0.000 claims description 13
125000000217 alkyl group Chemical group 0.000 claims description 11
125000000753 cycloalkyl group Chemical group 0.000 claims description 11
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
108010074860 Factor Xa Proteins 0.000 claims description 10
229910052717 sulfur Inorganic materials 0.000 claims description 10
125000000623 heterocyclic group Chemical group 0.000 claims description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 8
208000007536 Thrombosis Diseases 0.000 claims description 8
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
125000002619 bicyclic group Chemical group 0.000 claims description 8
125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 8
239000003795 chemical substances by application Substances 0.000 claims description 8
125000002950 monocyclic group Chemical group 0.000 claims description 8
239000000126 substance Substances 0.000 claims description 8
125000004434 sulfur atom Chemical group 0.000 claims description 8
125000003277 amino group Chemical group 0.000 claims description 7
239000003814 drug Substances 0.000 claims description 7
229910052760 oxygen Inorganic materials 0.000 claims description 7
238000007327 hydrogenolysis reaction Methods 0.000 claims description 6
206010002383 Angina Pectoris Diseases 0.000 claims description 5
206010003210 Arteriosclerosis Diseases 0.000 claims description 5
206010008190 Cerebrovascular accident Diseases 0.000 claims description 5
206010061218 Inflammation Diseases 0.000 claims description 5
208000006011 Stroke Diseases 0.000 claims description 5
238000002399 angioplasty Methods 0.000 claims description 5
208000011775 arteriosclerosis disease Diseases 0.000 claims description 5
229940079593 drug Drugs 0.000 claims description 5
229910052739 hydrogen Inorganic materials 0.000 claims description 5
239000001257 hydrogen Substances 0.000 claims description 5
230000004054 inflammatory process Effects 0.000 claims description 5
208000010125 myocardial infarction Diseases 0.000 claims description 5
239000000825 pharmaceutical preparation Substances 0.000 claims description 5
208000037803 restenosis Diseases 0.000 claims description 5
206010022562 Intermittent claudication Diseases 0.000 claims description 4
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
125000005842 heteroatom Chemical group 0.000 claims description 4
208000021156 intermittent vascular claudication Diseases 0.000 claims description 4
239000007788 liquid Substances 0.000 claims description 4
238000004519 manufacturing process Methods 0.000 claims description 4
239000001301 oxygen Substances 0.000 claims description 4
229920006395 saturated elastomer Polymers 0.000 claims description 4
BQKNCYMMOGNLIE-UHFFFAOYSA-N 4-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazine-1-carbonyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1 BQKNCYMMOGNLIE-UHFFFAOYSA-N 0.000 claims description 3
125000004093 cyano group Chemical group *C#N 0.000 claims description 3
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
150000004866 oxadiazoles Chemical class 0.000 claims description 3
230000008569 process Effects 0.000 claims description 3
230000009467 reduction Effects 0.000 claims description 3
230000010933 acylation Effects 0.000 claims description 2
238000005917 acylation reaction Methods 0.000 claims description 2
239000002552 dosage form Substances 0.000 claims description 2
125000004185 ester group Chemical group 0.000 claims description 2
239000007787 solid Substances 0.000 claims description 2
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
YMWCJRQRFNLRPO-UHFFFAOYSA-N 4-[4-(2-phenylethenylsulfonyl)piperazine-1-carbonyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(=O)N1CCN(S(=O)(=O)C=CC=2C=CC=CC=2)CC1 YMWCJRQRFNLRPO-UHFFFAOYSA-N 0.000 claims 1
MZSKTABWYFLIPP-UHFFFAOYSA-N 4-[4-(3-amino-4-chlorophenyl)sulfonylpiperazine-1-carbonyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(=O)N1CCN(S(=O)(=O)C=2C=C(N)C(Cl)=CC=2)CC1 MZSKTABWYFLIPP-UHFFFAOYSA-N 0.000 claims 1
IVDPHPQQNGBSTH-UHFFFAOYSA-N 4-[4-(4-propylphenyl)sulfonylpiperazine-1-carbonyl]benzenecarboximidamide Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C(N)=N)CC1 IVDPHPQQNGBSTH-UHFFFAOYSA-N 0.000 claims 1
230000003301 hydrolyzing effect Effects 0.000 claims 1
239000003112 inhibitor Substances 0.000 claims 1
239000011593 sulfur Substances 0.000 claims 1
-1 Aromatic amidine Chemical class 0.000 description 243
238000006243 chemical reaction Methods 0.000 description 46
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 34
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 30
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
238000005984 hydrogenation reaction Methods 0.000 description 15
239000000243 solution Substances 0.000 description 13
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
238000010626 work up procedure Methods 0.000 description 12
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 11
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 10
150000003254 radicals Chemical class 0.000 description 10
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
239000012442 inert solvent Substances 0.000 description 9
LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 8
FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 8
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 8
125000002252 acyl group Chemical group 0.000 description 8
239000000203 mixture Substances 0.000 description 8
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
239000002904 solvent Substances 0.000 description 8
239000007858 starting material Substances 0.000 description 8
150000007513 acids Chemical class 0.000 description 7
150000001409 amidines Chemical class 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
235000011054 acetic acid Nutrition 0.000 description 6
239000002585 base Substances 0.000 description 6
TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 6
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 6
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
239000003826 tablet Substances 0.000 description 6
LEFGAGRZHLNPLS-UHFFFAOYSA-N 4-propylbenzenesulfonyl chloride Chemical compound CCCC1=CC=C(S(Cl)(=O)=O)C=C1 LEFGAGRZHLNPLS-UHFFFAOYSA-N 0.000 description 5
IYFIYGSJZIICOZ-UHFFFAOYSA-N 6-chloronaphthalene-2-sulfonyl chloride Chemical compound C1=C(S(Cl)(=O)=O)C=CC2=CC(Cl)=CC=C21 IYFIYGSJZIICOZ-UHFFFAOYSA-N 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 5
208000035475 disorder Diseases 0.000 description 5
150000002825 nitriles Chemical class 0.000 description 5
230000009424 thromboembolic effect Effects 0.000 description 5
230000007306 turnover Effects 0.000 description 5
FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 4
XKDBKBMAWNBNRE-UHFFFAOYSA-N [amino(phenyl)methylidene]azanium;acetate Chemical compound CC(O)=O.NC(=N)C1=CC=CC=C1 XKDBKBMAWNBNRE-UHFFFAOYSA-N 0.000 description 4
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
125000003118 aryl group Chemical group 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
150000001735 carboxylic acids Chemical class 0.000 description 4
239000003054 catalyst Substances 0.000 description 4
VZWXIQHBIQLMPN-UHFFFAOYSA-N chromane Chemical compound C1=CC=C2CCCOC2=C1 VZWXIQHBIQLMPN-UHFFFAOYSA-N 0.000 description 4
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
150000002148 esters Chemical class 0.000 description 4
230000002401 inhibitory effect Effects 0.000 description 4
239000007924 injection Substances 0.000 description 4
238000002347 injection Methods 0.000 description 4
CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 4
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 4
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
229930192474 thiophene Natural products 0.000 description 4
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 3
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 3
ZHEYVXCFYIWQOM-UHFFFAOYSA-N 6-chloronaphthalene-1-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC2=CC(Cl)=CC=C21 ZHEYVXCFYIWQOM-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
239000007868 Raney catalyst Substances 0.000 description 3
229910000564 Raney nickel Inorganic materials 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
239000005864 Sulphur Substances 0.000 description 3
150000001298 alcohols Chemical class 0.000 description 3
150000001408 amides Chemical class 0.000 description 3
230000002785 anti-thrombosis Effects 0.000 description 3
125000003710 aryl alkyl group Chemical group 0.000 description 3
LHHCSNFAOIFYRV-DOVBMPENSA-N boceprevir Chemical compound O=C([C@@H]1[C@@H]2[C@@H](C2(C)C)CN1C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C)NC(C(=O)C(N)=O)CC1CCC1 LHHCSNFAOIFYRV-DOVBMPENSA-N 0.000 description 3
239000002775 capsule Substances 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
239000012154 double-distilled water Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 3
125000006125 ethylsulfonyl group Chemical group 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
OPECTNGATDYLSS-UHFFFAOYSA-N naphthalene-2-sulfonyl chloride Chemical compound C1=CC=CC2=CC(S(=O)(=O)Cl)=CC=C21 OPECTNGATDYLSS-UHFFFAOYSA-N 0.000 description 3
125000004430 oxygen atom Chemical group O* 0.000 description 3
239000000741 silica gel Substances 0.000 description 3
229910002027 silica gel Inorganic materials 0.000 description 3
239000000829 suppository Substances 0.000 description 3
239000000454 talc Substances 0.000 description 3
235000012222 talc Nutrition 0.000 description 3
229910052623 talc Inorganic materials 0.000 description 3
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical group COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 description 2
125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
RSJSYCZYQNJQPY-UHFFFAOYSA-N 3,4-dimethoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C=C1OC RSJSYCZYQNJQPY-UHFFFAOYSA-N 0.000 description 2
125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 description 2
125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
DTKAUYQBZSOHRJ-UHFFFAOYSA-N 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoic acid Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(O)=O)=N1 DTKAUYQBZSOHRJ-UHFFFAOYSA-N 0.000 description 2
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 2
DTJVECUKADWGMO-UHFFFAOYSA-N 4-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C=C1 DTJVECUKADWGMO-UHFFFAOYSA-N 0.000 description 2
125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
239000004365 Protease Substances 0.000 description 2
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
108090000190 Thrombin Proteins 0.000 description 2
CSGQUTFMONBCSR-UHFFFAOYSA-N [3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-piperazin-1-ylmethanone Chemical compound O1C(C)=NC(C=2C=C(C=CC=2)C(=O)N2CCNCC2)=N1 CSGQUTFMONBCSR-UHFFFAOYSA-N 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
229910052783 alkali metal Inorganic materials 0.000 description 2
150000001340 alkali metals Chemical class 0.000 description 2
229910052784 alkaline earth metal Inorganic materials 0.000 description 2
125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
239000003708 ampul Substances 0.000 description 2
239000003146 anticoagulant agent Substances 0.000 description 2
125000005279 aryl sulfonyloxy group Chemical group 0.000 description 2
CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 2
239000004305 biphenyl Substances 0.000 description 2
235000010290 biphenyl Nutrition 0.000 description 2
230000023555 blood coagulation Effects 0.000 description 2
230000037396 body weight Effects 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 2
WCKKWABZCCKDTN-UHFFFAOYSA-N decane-1-sulfonyl chloride Chemical compound CCCCCCCCCCS(Cl)(=O)=O WCKKWABZCCKDTN-UHFFFAOYSA-N 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
239000006196 drop Substances 0.000 description 2
150000002170 ethers Chemical class 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
239000012467 final product Substances 0.000 description 2
239000011737 fluorine Substances 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 2
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
239000004310 lactic acid Substances 0.000 description 2
235000014655 lactic acid Nutrition 0.000 description 2
239000008101 lactose Substances 0.000 description 2
125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
239000001630 malic acid Substances 0.000 description 2
235000011090 malic acid Nutrition 0.000 description 2
XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
150000004702 methyl esters Chemical class 0.000 description 2
125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
150000007522 mineralic acids Chemical class 0.000 description 2
PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
DASJFYAPNPUBGG-UHFFFAOYSA-N naphthalene-1-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 DASJFYAPNPUBGG-UHFFFAOYSA-N 0.000 description 2
LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 2
239000002674 ointment Substances 0.000 description 2
WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 2
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 2
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
OAHKWDDSKCRNFE-UHFFFAOYSA-N phenylmethanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC=C1 OAHKWDDSKCRNFE-UHFFFAOYSA-N 0.000 description 2
125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
235000011007 phosphoric acid Nutrition 0.000 description 2
239000006187 pill Substances 0.000 description 2
WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
IVXQBCUBSIPQGU-UHFFFAOYSA-N piperazine-1-carboxamide Chemical compound NC(=O)N1CCNCC1 IVXQBCUBSIPQGU-UHFFFAOYSA-N 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
229920001592 potato starch Polymers 0.000 description 2
239000000843 powder Substances 0.000 description 2
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 2
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
239000011734 sodium Substances 0.000 description 2
238000011146 sterile filtration Methods 0.000 description 2
150000003460 sulfonic acids Chemical class 0.000 description 2
239000011975 tartaric acid Substances 0.000 description 2
235000002906 tartaric acid Nutrition 0.000 description 2
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
229960004072 thrombin Drugs 0.000 description 2
238000011200 topical administration Methods 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
CFNMHCWDZSUUQI-UHFFFAOYSA-N (2-methyl-5-nitrophenyl)methanesulfonyl chloride Chemical compound CC1=CC=C([N+]([O-])=O)C=C1CS(Cl)(=O)=O CFNMHCWDZSUUQI-UHFFFAOYSA-N 0.000 description 1
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 description 1
JUSWZYFYLXTMLJ-JTQLQIEISA-N (2s)-1-(benzenesulfonyl)pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1S(=O)(=O)C1=CC=CC=C1 JUSWZYFYLXTMLJ-JTQLQIEISA-N 0.000 description 1
RQYKQWFHJOBBAO-JTQLQIEISA-N (2s)-1-benzoylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)C1=CC=CC=C1 RQYKQWFHJOBBAO-JTQLQIEISA-N 0.000 description 1
YRAYVSQKHFMWKM-UHFFFAOYSA-N (4-benzylsulfonylpiperazin-1-yl)-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)CC=2C=CC=CC=2)=N1 YRAYVSQKHFMWKM-UHFFFAOYSA-N 0.000 description 1
BDKYWVUHHLJYDF-UHFFFAOYSA-N (4-decylsulfonylpiperazin-1-yl)-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound C1CN(S(=O)(=O)CCCCCCCCCC)CCN1C(=O)C1=CC=C(C=2N=C(C)ON=2)C=C1 BDKYWVUHHLJYDF-UHFFFAOYSA-N 0.000 description 1
ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 1
125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
ZRSGZIMDIHBXIN-UHFFFAOYSA-N 1,3-benzodioxole-5-carbonyl chloride Chemical compound ClC(=O)C1=CC=C2OCOC2=C1 ZRSGZIMDIHBXIN-UHFFFAOYSA-N 0.000 description 1
RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
OMLXLSWPGNPGPU-UHFFFAOYSA-N 1-(2,4,6-trimethylphenyl)sulfonylpiperazine Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)N1CCNCC1 OMLXLSWPGNPGPU-UHFFFAOYSA-N 0.000 description 1
RKZQNDSKKYMCBA-UHFFFAOYSA-N 1-(2-phenylethenylsulfonyl)piperazine Chemical compound C1CNCCN1S(=O)(=O)C=CC1=CC=CC=C1 RKZQNDSKKYMCBA-UHFFFAOYSA-N 0.000 description 1
AMFSRRVNNJMVEJ-UHFFFAOYSA-N 1-(4-benzylsulfonylpiperazin-1-yl)-2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]ethanone Chemical compound O1C(C)=NC(C=2C=CC(CC(=O)N3CCN(CC3)S(=O)(=O)CC=3C=CC=CC=3)=CC=2)=N1 AMFSRRVNNJMVEJ-UHFFFAOYSA-N 0.000 description 1
CKVKEBVACPUEIB-UHFFFAOYSA-N 1-(4-chlorophenyl)sulfonylpiperazine Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1CCNCC1 CKVKEBVACPUEIB-UHFFFAOYSA-N 0.000 description 1
GORMTLXDLRUYIT-UHFFFAOYSA-N 1-(4-decylsulfonylpiperazin-1-yl)-2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]ethanone Chemical compound C1CN(S(=O)(=O)CCCCCCCCCC)CCN1C(=O)CC1=CC=C(C=2N=C(C)ON=2)C=C1 GORMTLXDLRUYIT-UHFFFAOYSA-N 0.000 description 1
UJGNXLDOTDJYGH-UHFFFAOYSA-N 1-(4-propylphenyl)sulfonylpiperazine Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCNCC1 UJGNXLDOTDJYGH-UHFFFAOYSA-N 0.000 description 1
FMLPGZYYCBFFLU-UHFFFAOYSA-N 1-(6-chloronaphthalen-2-yl)sulfonylpiperazine Chemical compound C1=CC2=CC(Cl)=CC=C2C=C1S(=O)(=O)N1CCNCC1 FMLPGZYYCBFFLU-UHFFFAOYSA-N 0.000 description 1
CCAWDIFJOBKBSE-UHFFFAOYSA-N 1-(chloromethyl)-3,5-dimethoxybenzene Chemical compound COC1=CC(CCl)=CC(OC)=C1 CCAWDIFJOBKBSE-UHFFFAOYSA-N 0.000 description 1
MEPBLENVCZDFNJ-UHFFFAOYSA-N 1-[4-(2,1,3-benzothiadiazol-4-ylsulfonyl)piperazin-1-yl]-2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]ethanone Chemical compound O1C(C)=NC(C=2C=CC(CC(=O)N3CCN(CC3)S(=O)(=O)C=3C4=NSN=C4C=CC=3)=CC=2)=N1 MEPBLENVCZDFNJ-UHFFFAOYSA-N 0.000 description 1
FKOCEPBYEMPNOO-UHFFFAOYSA-N 1-[4-(3,4-dichlorophenyl)sulfonylpiperazin-1-yl]-2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]ethanone Chemical compound O1C(C)=NC(C=2C=CC(CC(=O)N3CCN(CC3)S(=O)(=O)C=3C=C(Cl)C(Cl)=CC=3)=CC=2)=N1 FKOCEPBYEMPNOO-UHFFFAOYSA-N 0.000 description 1
YFLDOMARCHZTIV-UHFFFAOYSA-N 1-[4-(3,4-dimethoxyphenyl)sulfonylpiperazin-1-yl]-2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]ethanone Chemical compound C1=C(OC)C(OC)=CC=C1S(=O)(=O)N1CCN(C(=O)CC=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 YFLDOMARCHZTIV-UHFFFAOYSA-N 0.000 description 1
RGVFXCOITFAXIV-UHFFFAOYSA-N 1-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]-3-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]propan-1-one Chemical compound O1C(C)=NC(C=2C=CC(CCC(=O)N3CCN(CC3)S(=O)(=O)C=3C=C4C=CC(Cl)=CC4=CC=3)=CC=2)=N1 RGVFXCOITFAXIV-UHFFFAOYSA-N 0.000 description 1
OQBNZUOWINHNTN-UHFFFAOYSA-N 1-[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]-2-phenoxyethanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)COC=2C=CC=CC=2)=N1 OQBNZUOWINHNTN-UHFFFAOYSA-N 0.000 description 1
DNGLRCHMGDDHNC-UHFFFAOYSA-N 1-benzothiophene-2-carbonyl chloride Chemical compound C1=CC=C2SC(C(=O)Cl)=CC2=C1 DNGLRCHMGDDHNC-UHFFFAOYSA-N 0.000 description 1
125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
125000006219 1-ethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
QZTWVDCKDWZCLV-UHFFFAOYSA-N 1-isocyanato-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(N=C=O)C=C1 QZTWVDCKDWZCLV-UHFFFAOYSA-N 0.000 description 1
FMDGXCSMDZMDHZ-UHFFFAOYSA-N 1-isocyanato-4-methoxybenzene Chemical compound COC1=CC=C(N=C=O)C=C1 FMDGXCSMDZMDHZ-UHFFFAOYSA-N 0.000 description 1
GFNKTLQTQSALEJ-UHFFFAOYSA-N 1-isocyanato-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(N=C=O)C=C1 GFNKTLQTQSALEJ-UHFFFAOYSA-N 0.000 description 1
BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 1
OJWPAXRMRPPQBG-UHFFFAOYSA-N 1-naphthalen-2-ylsulfonylpiperazine Chemical compound C=1C=C2C=CC=CC2=CC=1S(=O)(=O)N1CCNCC1 OJWPAXRMRPPQBG-UHFFFAOYSA-N 0.000 description 1
125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
CXAICGCTHOWKPP-UHFFFAOYSA-N 2,1,3-benzothiadiazole-4-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC2=NSN=C12 CXAICGCTHOWKPP-UHFFFAOYSA-N 0.000 description 1
PQODWTNHDKDHIW-UHFFFAOYSA-N 2,3-dichlorobenzenesulfonyl chloride Chemical compound ClC1=CC=CC(S(Cl)(=O)=O)=C1Cl PQODWTNHDKDHIW-UHFFFAOYSA-N 0.000 description 1
125000005808 2,4,6-trimethoxyphenyl group Chemical group [H][#6]-1=[#6](-[#8]C([H])([H])[H])-[#6](-*)=[#6](-[#8]C([H])([H])[H])-[#6]([H])=[#6]-1-[#8]C([H])([H])[H] 0.000 description 1
PVJZBZSCGJAWNG-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonyl chloride Chemical compound CC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1 PVJZBZSCGJAWNG-UHFFFAOYSA-N 0.000 description 1
BXCOSWRSIISQSL-UHFFFAOYSA-N 2,5-dichlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(Cl)C(S(Cl)(=O)=O)=C1 BXCOSWRSIISQSL-UHFFFAOYSA-N 0.000 description 1
GCXPJRMNDARTJW-UHFFFAOYSA-N 2-(2,5-dimethoxyphenyl)-1-[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]ethanone Chemical compound COC1=CC=C(OC)C(CC(=O)N2CCN(CC2)C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)=C1 GCXPJRMNDARTJW-UHFFFAOYSA-N 0.000 description 1
RAPIPBRHRYSAHQ-UHFFFAOYSA-N 2-(2,5-dimethoxyphenyl)acetyl chloride Chemical compound COC1=CC=C(OC)C(CC(Cl)=O)=C1 RAPIPBRHRYSAHQ-UHFFFAOYSA-N 0.000 description 1
ICMYBXSQADZKHQ-UHFFFAOYSA-N 2-(4-carbamimidoyl-n-(4-naphthalen-2-ylsulfonylpiperazine-1-carbonyl)anilino)acetic acid Chemical compound C1=CC(C(=N)N)=CC=C1N(CC(O)=O)C(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC=CC3=CC=2)CC1 ICMYBXSQADZKHQ-UHFFFAOYSA-N 0.000 description 1
SYYUMMQQTQFEJF-UHFFFAOYSA-N 2-(4-carbamimidoyl-n-[4-(2-phenylethenylsulfonyl)piperazine-1-carbonyl]anilino)acetic acid Chemical compound C1=CC(C(=N)N)=CC=C1N(CC(O)=O)C(=O)N1CCN(S(=O)(=O)C=CC=2C=CC=CC=2)CC1 SYYUMMQQTQFEJF-UHFFFAOYSA-N 0.000 description 1
GNKMRAUHEGDXLE-UHFFFAOYSA-N 2-(4-carbamimidoyl-n-[4-(4-phenylphenyl)sulfonylpiperazine-1-carbonyl]anilino)acetic acid Chemical compound C1=CC(C(=N)N)=CC=C1N(CC(O)=O)C(=O)N1CCN(S(=O)(=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)CC1 GNKMRAUHEGDXLE-UHFFFAOYSA-N 0.000 description 1
MMUJRDIBPXQPDD-UHFFFAOYSA-N 2-(4-carbamimidoyl-n-[4-(4-propylphenyl)sulfonylpiperazine-1-carbonyl]anilino)acetic acid Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)N(CC(O)=O)C=2C=CC(=CC=2)C(N)=N)CC1 MMUJRDIBPXQPDD-UHFFFAOYSA-N 0.000 description 1
DLPNIJAEZDNGCV-UHFFFAOYSA-N 2-(4-carbamimidoyl-n-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazine-1-carbonyl]anilino)acetic acid Chemical compound C1=CC(C(=N)N)=CC=C1N(CC(O)=O)C(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1 DLPNIJAEZDNGCV-UHFFFAOYSA-N 0.000 description 1
JNDSOWJSURFZPP-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-4-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)-4-oxobutanoic acid Chemical compound C1=CC(C(=N)N)=CC=C1C(C(O)=O)CC(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC=CC3=CC=2)CC1 JNDSOWJSURFZPP-UHFFFAOYSA-N 0.000 description 1
GVNJJBBLTHAVGZ-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-4-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]-4-oxobutanoic acid Chemical compound C1=CC(C(=N)N)=CC=C1C(C(O)=O)CC(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1 GVNJJBBLTHAVGZ-UHFFFAOYSA-N 0.000 description 1
BTVSPJDDFCJXBO-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-4-oxo-4-[4-(2-phenylethenylsulfonyl)piperazin-1-yl]butanoic acid Chemical compound C1=CC(C(=N)N)=CC=C1C(C(O)=O)CC(=O)N1CCN(S(=O)(=O)C=CC=2C=CC=CC=2)CC1 BTVSPJDDFCJXBO-UHFFFAOYSA-N 0.000 description 1
BZGQNIWAQFBYRN-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-4-oxo-4-[4-(4-phenylphenyl)sulfonylpiperazin-1-yl]butanoic acid Chemical compound C1=CC(C(=N)N)=CC=C1C(C(O)=O)CC(=O)N1CCN(S(=O)(=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)CC1 BZGQNIWAQFBYRN-UHFFFAOYSA-N 0.000 description 1
RQPYMPWPCHFLDY-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-4-oxo-4-[4-(4-propylphenyl)sulfonylpiperazin-1-yl]butanoic acid Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)CC(C(O)=O)C=2C=CC(=CC=2)C(N)=N)CC1 RQPYMPWPCHFLDY-UHFFFAOYSA-N 0.000 description 1
DSZXHLVPFXHBFK-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]ethanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)CC=2C=CC(Cl)=CC=2)=N1 DSZXHLVPFXHBFK-UHFFFAOYSA-N 0.000 description 1
UMQUIRYNOVNYPA-UHFFFAOYSA-N 2-(4-chlorophenyl)acetyl chloride Chemical compound ClC(=O)CC1=CC=C(Cl)C=C1 UMQUIRYNOVNYPA-UHFFFAOYSA-N 0.000 description 1
MPCHQYWZAVTABQ-UHFFFAOYSA-N 2-(chloromethyl)naphthalene Chemical compound C1=CC=CC2=CC(CCl)=CC=C21 MPCHQYWZAVTABQ-UHFFFAOYSA-N 0.000 description 1
UZYQSNQJLWTICD-UHFFFAOYSA-N 2-(n-benzoylanilino)-2,2-dinitroacetic acid Chemical compound C=1C=CC=CC=1N(C(C(=O)O)([N+]([O-])=O)[N+]([O-])=O)C(=O)C1=CC=CC=C1 UZYQSNQJLWTICD-UHFFFAOYSA-N 0.000 description 1
OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
ZNBQLRSWJYQMES-UHFFFAOYSA-N 2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1-(4-naphthalen-1-ylsulfonylpiperazin-1-yl)ethanone Chemical compound O1C(C)=NC(C=2C=CC(CC(=O)N3CCN(CC3)S(=O)(=O)C=3C4=CC=CC=C4C=CC=3)=CC=2)=N1 ZNBQLRSWJYQMES-UHFFFAOYSA-N 0.000 description 1
ZKPUHQFROWHGPC-UHFFFAOYSA-N 2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)ethanone Chemical compound O1C(C)=NC(C=2C=CC(CC(=O)N3CCN(CC3)S(=O)(=O)C=3C=C4C=CC=CC4=CC=3)=CC=2)=N1 ZKPUHQFROWHGPC-UHFFFAOYSA-N 0.000 description 1
BNEUDWYUCWESGY-UHFFFAOYSA-N 2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1-(4-propan-2-ylsulfonylpiperazin-1-yl)ethanone Chemical compound C1CN(S(=O)(=O)C(C)C)CCN1C(=O)CC1=CC=C(C=2N=C(C)ON=2)C=C1 BNEUDWYUCWESGY-UHFFFAOYSA-N 0.000 description 1
PLYONGSRFNFPEF-UHFFFAOYSA-N 2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1-[4-(2,4,6-trimethylphenyl)sulfonylpiperazin-1-yl]ethanone 2,4,6-trimethylbenzenesulfonyl chloride Chemical compound Cc1cc(C)c(c(C)c1)S(Cl)(=O)=O.Cc1nc(no1)-c1ccc(CC(=O)N2CCN(CC2)S(=O)(=O)c2c(C)cc(C)cc2C)cc1 PLYONGSRFNFPEF-UHFFFAOYSA-N 0.000 description 1
DVWGZDDMSSNEIM-UHFFFAOYSA-N 2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1-[4-(4-propylphenyl)sulfonylpiperazin-1-yl]ethanone Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)CC=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 DVWGZDDMSSNEIM-UHFFFAOYSA-N 0.000 description 1
SRUOVCPOBZBHMG-UHFFFAOYSA-N 2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1-piperazin-1-ylethanone Chemical compound O1C(C)=NC(C=2C=CC(CC(=O)N3CCNCC3)=CC=2)=N1 SRUOVCPOBZBHMG-UHFFFAOYSA-N 0.000 description 1
SCQAUEYGYGFQIQ-UHFFFAOYSA-N 2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]acetic acid Chemical compound O1C(C)=NC(C=2C=CC(CC(O)=O)=CC=2)=N1 SCQAUEYGYGFQIQ-UHFFFAOYSA-N 0.000 description 1
KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
BJYNYQGJTZULJI-UHFFFAOYSA-N 2-methoxy-5-methylbenzenesulfonyl chloride Chemical compound COC1=CC=C(C)C=C1S(Cl)(=O)=O BJYNYQGJTZULJI-UHFFFAOYSA-N 0.000 description 1
125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
125000005916 2-methylpentyl group Chemical group 0.000 description 1
PEVFJTMXKKADBR-UHFFFAOYSA-N 2-methylpropyl 4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC(C)C)CCN1C(=O)C1=CC=C(C=2N=C(C)ON=2)C=C1 PEVFJTMXKKADBR-UHFFFAOYSA-N 0.000 description 1
YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
PKUPAJQAJXVUEK-UHFFFAOYSA-N 2-phenoxyacetyl chloride Chemical compound ClC(=O)COC1=CC=CC=C1 PKUPAJQAJXVUEK-UHFFFAOYSA-N 0.000 description 1
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
125000004362 3,4,5-trichlorophenyl group Chemical group [H]C1=C(Cl)C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
NYIBPWGZGSXURD-UHFFFAOYSA-N 3,4-dichlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1Cl NYIBPWGZGSXURD-UHFFFAOYSA-N 0.000 description 1
SHNFSARCTLLYMS-UHFFFAOYSA-N 3,4-dichlorobenzenesulfonyl chloride;[4-(3,4-dichlorophenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1Cl.O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=C(Cl)C(Cl)=CC=2)=N1 SHNFSARCTLLYMS-UHFFFAOYSA-N 0.000 description 1
VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
FSGLUBQENACWCC-UHFFFAOYSA-N 3,4-difluorobenzenesulfonyl chloride Chemical compound FC1=CC=C(S(Cl)(=O)=O)C=C1F FSGLUBQENACWCC-UHFFFAOYSA-N 0.000 description 1
125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
GZLPFEYTAAXJCP-UHFFFAOYSA-N 3,5-dimethyl-1,2-oxazole-4-sulfonyl chloride Chemical compound CC1=NOC(C)=C1S(Cl)(=O)=O GZLPFEYTAAXJCP-UHFFFAOYSA-N 0.000 description 1
MIFHXAPYMFWFCP-UHFFFAOYSA-N 3-(4-isocyanatophenyl)-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)N=C=O)=N1 MIFHXAPYMFWFCP-UHFFFAOYSA-N 0.000 description 1
LXGJRZCNBSCWHV-UHFFFAOYSA-N 3-[4-(4-butylsulfonylpiperazin-1-yl)phenyl]-5-methyl-1,2,4-oxadiazole Chemical compound C1CN(S(=O)(=O)CCCC)CCN1C1=CC=C(C=2N=C(C)ON=2)C=C1 LXGJRZCNBSCWHV-UHFFFAOYSA-N 0.000 description 1
UWXJEEFTENFOBR-UHFFFAOYSA-N 3-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-1-piperazin-1-ylpropan-1-one Chemical compound O1C(C)=NC(C=2C=CC(CCC(=O)N3CCNCC3)=CC=2)=N1 UWXJEEFTENFOBR-UHFFFAOYSA-N 0.000 description 1
OAJJAFVZMPMLGR-UHFFFAOYSA-N 3-[4-[4-(3-chloro-4-methylphenyl)sulfonylpiperazin-1-yl]phenyl]-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)N2CCN(CC2)S(=O)(=O)C=2C=C(Cl)C(C)=CC=2)=N1 OAJJAFVZMPMLGR-UHFFFAOYSA-N 0.000 description 1
MZXKOXTVAYRURZ-UHFFFAOYSA-N 3-[4-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]phenyl]-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)N2CCN(CC2)S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)=N1 MZXKOXTVAYRURZ-UHFFFAOYSA-N 0.000 description 1
NXTXDYDRDZXNIA-UHFFFAOYSA-N 3-[4-[[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]methyl]phenyl]-5-methyl-1,2,4-oxadiazole Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(CC=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 NXTXDYDRDZXNIA-UHFFFAOYSA-N 0.000 description 1
NCMOPRMLOBMTBT-UHFFFAOYSA-N 3-[4-[[4-[(3,5-dimethoxyphenyl)methyl]piperazin-1-yl]methyl]phenyl]-5-methyl-1,2,4-oxadiazole Chemical compound COC1=CC(OC)=CC(CN2CCN(CC=3C=CC(=CC=3)C=3N=C(C)ON=3)CC2)=C1 NCMOPRMLOBMTBT-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
GNYVVCRRZRVBDD-UHFFFAOYSA-N 3-chloro-4-methylbenzenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1Cl GNYVVCRRZRVBDD-UHFFFAOYSA-N 0.000 description 1
125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
KFPMLWUKHQMEBU-UHFFFAOYSA-N 3-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC(S(Cl)(=O)=O)=C1 KFPMLWUKHQMEBU-UHFFFAOYSA-N 0.000 description 1
125000005917 3-methylpentyl group Chemical group 0.000 description 1
NXTNASSYJUXJDV-UHFFFAOYSA-N 3-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(C(Cl)=O)=C1 NXTNASSYJUXJDV-UHFFFAOYSA-N 0.000 description 1
125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
BKYPFWBBHJMODH-UHFFFAOYSA-N 4-(4-chlorophenyl)sulfonyl-n-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(NC(=O)N3CCN(CC3)S(=O)(=O)C=3C=CC(Cl)=CC=3)=CC=2)=N1 BKYPFWBBHJMODH-UHFFFAOYSA-N 0.000 description 1
SMBDBBBBXFXBSK-UHFFFAOYSA-N 4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl chloride Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(Cl)=O)=N1 SMBDBBBBXFXBSK-UHFFFAOYSA-N 0.000 description 1
VAPPPANHCHPMGO-UHFFFAOYSA-N 4-(6-chloronaphthalen-2-yl)sulfonyl-n-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(NC(=O)N3CCN(CC3)S(=O)(=O)C=3C=C4C=CC(Cl)=CC4=CC=3)=CC=2)=N1 VAPPPANHCHPMGO-UHFFFAOYSA-N 0.000 description 1
UMLFTCYAQPPZER-UHFFFAOYSA-N 4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1 UMLFTCYAQPPZER-UHFFFAOYSA-N 0.000 description 1
ZXKKOFJYPRJFIE-UHFFFAOYSA-N 4-(trifluoromethoxy)benzoyl chloride Chemical compound FC(F)(F)OC1=CC=C(C(Cl)=O)C=C1 ZXKKOFJYPRJFIE-UHFFFAOYSA-N 0.000 description 1
UKCPJXYXPORZQT-UHFFFAOYSA-N 4-[(4-phenylphenyl)sulfonyl-piperazin-1-ylmethyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(S(=O)(=O)C=1C=CC(=CC=1)C=1C=CC=CC=1)N1CCNCC1 UKCPJXYXPORZQT-UHFFFAOYSA-N 0.000 description 1
BWPXASBMFRJJSC-UHFFFAOYSA-N 4-[(6-chloronaphthalen-2-yl)sulfonyl-piperazin-1-ylmethyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(S(=O)(=O)C=1C=C2C=CC(Cl)=CC2=CC=1)N1CCNCC1 BWPXASBMFRJJSC-UHFFFAOYSA-N 0.000 description 1
RSGJOFCDZUANDR-UHFFFAOYSA-N 4-[2-oxo-2-[4-(4-propylphenyl)sulfonylpiperazin-1-yl]ethyl]benzenecarboximidamide Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)CC=2C=CC(=CC=2)C(N)=N)CC1 RSGJOFCDZUANDR-UHFFFAOYSA-N 0.000 description 1
CXLTTZVWIIKGNT-UHFFFAOYSA-N 4-[2-phenylethenylsulfonyl(piperazin-1-yl)methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(S(=O)(=O)C=CC=1C=CC=CC=1)N1CCNCC1 CXLTTZVWIIKGNT-UHFFFAOYSA-N 0.000 description 1
ZAIHLGGJTAYQSK-UHFFFAOYSA-N 4-[3-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]-3-oxopropyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CCC(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1 ZAIHLGGJTAYQSK-UHFFFAOYSA-N 0.000 description 1
WHOUDGKKXISPOY-UHFFFAOYSA-N 4-[4-(3-aminobenzoyl)piperazine-1-carbonyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(=O)N1CCN(C(=O)C=2C=C(N)C=CC=2)CC1 WHOUDGKKXISPOY-UHFFFAOYSA-N 0.000 description 1
TXBDOWJTBJPVKM-UHFFFAOYSA-N 4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]-n-(4-nitrophenyl)piperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)NC=2C=CC(=CC=2)[N+]([O-])=O)=N1 TXBDOWJTBJPVKM-UHFFFAOYSA-N 0.000 description 1
XGROWXCLDADPHD-UHFFFAOYSA-N 4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]-n-naphthalen-1-ylpiperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)NC=2C3=CC=CC=C3C=CC=2)=N1 XGROWXCLDADPHD-UHFFFAOYSA-N 0.000 description 1
MBPLGDZACSYTMO-UHFFFAOYSA-N 4-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazine-1-carbonyl]-3-methylbenzenecarboximidamide Chemical compound CC1=CC(C(N)=N)=CC=C1C(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1 MBPLGDZACSYTMO-UHFFFAOYSA-N 0.000 description 1
GFTPIDWHZJGMLG-UHFFFAOYSA-N 4-[naphthalen-2-ylsulfonyl(piperazin-1-yl)methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C(S(=O)(=O)C=1C=C2C=CC=CC2=CC=1)N1CCNCC1 GFTPIDWHZJGMLG-UHFFFAOYSA-N 0.000 description 1
ALOQYFFSHSEVJH-UHFFFAOYSA-N 4-acetamido-3-chlorobenzenesulfonyl chloride Chemical compound CC(=O)NC1=CC=C(S(Cl)(=O)=O)C=C1Cl ALOQYFFSHSEVJH-UHFFFAOYSA-N 0.000 description 1
GRDXCFKBQWDAJH-UHFFFAOYSA-N 4-acetamidobenzenesulfonyl chloride Chemical compound CC(=O)NC1=CC=C(S(Cl)(=O)=O)C=C1 GRDXCFKBQWDAJH-UHFFFAOYSA-N 0.000 description 1
UOIVESXBURLTPX-UHFFFAOYSA-N 4-bromo-2-ethylbenzenesulfonyl chloride Chemical compound CCC1=CC(Br)=CC=C1S(Cl)(=O)=O UOIVESXBURLTPX-UHFFFAOYSA-N 0.000 description 1
OVFZELSNOHIDEF-UHFFFAOYSA-N 4-butylbenzenesulfonyl chloride Chemical compound CCCCC1=CC=C(S(Cl)(=O)=O)C=C1 OVFZELSNOHIDEF-UHFFFAOYSA-N 0.000 description 1
JBYZPUBAISWVDI-UHFFFAOYSA-N 4-chloro-2,5-dimethylbenzenesulfonyl chloride Chemical compound CC1=CC(S(Cl)(=O)=O)=C(C)C=C1Cl JBYZPUBAISWVDI-UHFFFAOYSA-N 0.000 description 1
ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 4-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1 ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 0.000 description 1
LACFLXDRFOQEFZ-UHFFFAOYSA-N 4-ethylbenzenesulfonyl chloride Chemical compound CCC1=CC=C(S(Cl)(=O)=O)C=C1 LACFLXDRFOQEFZ-UHFFFAOYSA-N 0.000 description 1
125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 1
OGHAPVZVXLHURO-UHFFFAOYSA-N 4-methoxy-2-nitrobenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C([N+]([O-])=O)=C1 OGHAPVZVXLHURO-UHFFFAOYSA-N 0.000 description 1
TYJOQICPGZGYDT-UHFFFAOYSA-N 4-methylsulfonylbenzenesulfonyl chloride Chemical compound CS(=O)(=O)C1=CC=C(S(Cl)(=O)=O)C=C1 TYJOQICPGZGYDT-UHFFFAOYSA-N 0.000 description 1
JPVUWCPKMYXOKW-UHFFFAOYSA-N 4-phenylbenzoyl chloride Chemical compound C1=CC(C(=O)Cl)=CC=C1C1=CC=CC=C1 JPVUWCPKMYXOKW-UHFFFAOYSA-N 0.000 description 1
125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical compound [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
PBXXVZQVRUKRKC-UHFFFAOYSA-N 5-(dimethylamino)naphthalene-1-sulfonyl chloride 1-[4-[5-(dimethylamino)naphthalen-1-yl]sulfonylpiperazin-1-yl]-2-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]ethanone Chemical compound CN(C)c1cccc2c(cccc12)S(Cl)(=O)=O.CN(C)c1cccc2c(cccc12)S(=O)(=O)N1CCN(CC1)C(=O)Cc1ccc(cc1)-c1noc(C)n1 PBXXVZQVRUKRKC-UHFFFAOYSA-N 0.000 description 1
BWVNHXIGDZASCP-UHFFFAOYSA-N 5-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]thiophene-2-sulfonyl chloride Chemical compound C1=C(C(F)(F)F)N(C)N=C1C1=CC=C(S(Cl)(=O)=O)S1 BWVNHXIGDZASCP-UHFFFAOYSA-N 0.000 description 1
125000004539 5-benzimidazolyl group Chemical group N1=CNC2=C1C=CC(=C2)* 0.000 description 1
HWGVUNSKAPCFNF-UHFFFAOYSA-N 5-chloro-1,3-dimethylpyrazole-4-sulfonyl chloride Chemical compound CC1=NN(C)C(Cl)=C1S(Cl)(=O)=O HWGVUNSKAPCFNF-UHFFFAOYSA-N 0.000 description 1
MICVPVPQQNFKGU-UHFFFAOYSA-N 5-chloronaphthalene-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=C2C(Cl)=CC=CC2=C1 MICVPVPQQNFKGU-UHFFFAOYSA-N 0.000 description 1
NPNTVEOHEIJADR-UHFFFAOYSA-N 5-methyl-3-(4-piperazin-1-ylphenyl)-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)N2CCNCC2)=N1 NPNTVEOHEIJADR-UHFFFAOYSA-N 0.000 description 1
XIRGQQZVRFVVEW-UHFFFAOYSA-N 5-methyl-3-[4-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)phenyl]-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)N2CCN(CC2)S(=O)(=O)C=2C=C3C=CC=CC3=CC=2)=N1 XIRGQQZVRFVVEW-UHFFFAOYSA-N 0.000 description 1
VJRDYURNXPQISC-UHFFFAOYSA-N 5-methyl-3-[4-(piperazin-1-ylmethyl)phenyl]-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(CN3CCNCC3)=CC=2)=N1 VJRDYURNXPQISC-UHFFFAOYSA-N 0.000 description 1
PZVYUAHCDZJODN-UHFFFAOYSA-N 5-methyl-3-[4-[4-(2,4,6-trimethylphenyl)sulfonylpiperazin-1-yl]phenyl]-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)N2CCN(CC2)S(=O)(=O)C=2C(=CC(C)=CC=2C)C)=N1 PZVYUAHCDZJODN-UHFFFAOYSA-N 0.000 description 1
FMLLHWFPVZDTCC-UHFFFAOYSA-N 5-methyl-3-[4-[4-(4-propylphenyl)sulfonylpiperazin-1-yl]phenyl]-1,2,4-oxadiazole Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 FMLLHWFPVZDTCC-UHFFFAOYSA-N 0.000 description 1
SLNZRZNAEQHSAA-UHFFFAOYSA-N 5-methyl-3-[4-[[4-(4-propylphenyl)sulfonylpiperazin-1-yl]methyl]phenyl]-1,2,4-oxadiazole Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(CC=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 SLNZRZNAEQHSAA-UHFFFAOYSA-N 0.000 description 1
YAOVXDACVMPREX-UHFFFAOYSA-N 5-methyl-3-[4-[[4-(naphthalen-2-ylmethyl)piperazin-1-yl]methyl]phenyl]-1,2,4-oxadiazole Chemical compound O1C(C)=NC(C=2C=CC(CN3CCN(CC=4C=C5C=CC=CC5=CC=4)CC3)=CC=2)=N1 YAOVXDACVMPREX-UHFFFAOYSA-N 0.000 description 1
CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
LOYHMYJZBTXBGW-UHFFFAOYSA-N C(C)(=O)O.BrC=1C=C(C=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.BrC=1C=C(C=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 LOYHMYJZBTXBGW-UHFFFAOYSA-N 0.000 description 1
IKVAYEZKPZXRSQ-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)NC1=C(C=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)Cl Chemical compound C(C)(=O)O.C(C)(=O)NC1=C(C=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)Cl IKVAYEZKPZXRSQ-UHFFFAOYSA-N 0.000 description 1
ZPLZFRFZGYFWPN-UHFFFAOYSA-N C(C)(=O)O.C(C)(C)(C)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.C(C)(C)(C)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 ZPLZFRFZGYFWPN-UHFFFAOYSA-N 0.000 description 1
WMXKSDKSZLWFIT-UHFFFAOYSA-N C(C)(=O)O.C(C)(C)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.C(C)(C)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 WMXKSDKSZLWFIT-UHFFFAOYSA-N 0.000 description 1
HVCYUNHPBKMOND-UHFFFAOYSA-N C(C)(=O)O.C(CC)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.C(CC)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 HVCYUNHPBKMOND-UHFFFAOYSA-N 0.000 description 1
OUJRUCKYSONBAV-UHFFFAOYSA-N C(C)(=O)O.C(CCCCCCCCC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.C(CCCCCCCCC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 OUJRUCKYSONBAV-UHFFFAOYSA-N 0.000 description 1
MASRCPUDQHDKEI-UHFFFAOYSA-N C(C)(=O)O.C(N)(=N)C1=CC=C(C=C1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1 Chemical compound C(C)(=O)O.C(N)(=N)C1=CC=C(C=C1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1 MASRCPUDQHDKEI-UHFFFAOYSA-N 0.000 description 1
CXIXWMGGRGEVJP-UHFFFAOYSA-N C(C)(=O)O.C(N)(=N)C1=CC=C(CN2CCN(CC2)CC2=CC(=CC(=C2)OC)OC)C=C1 Chemical compound C(C)(=O)O.C(N)(=N)C1=CC=C(CN2CCN(CC2)CC2=CC(=CC(=C2)OC)OC)C=C1 CXIXWMGGRGEVJP-UHFFFAOYSA-N 0.000 description 1
HYIZPUKZLHYUGA-UHFFFAOYSA-N C(C)(=O)O.C1(=CC(=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C Chemical compound C(C)(=O)O.C1(=CC(=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C HYIZPUKZLHYUGA-UHFFFAOYSA-N 0.000 description 1
NIXARMLKWNLUGS-UHFFFAOYSA-N C(C)(=O)O.C1(=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C Chemical compound C(C)(=O)O.C1(=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C NIXARMLKWNLUGS-UHFFFAOYSA-N 0.000 description 1
XWKFJNWYADOUCL-UHFFFAOYSA-N C(C)(=O)O.C1(=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1)C1=CC=CC=C1 Chemical compound C(C)(=O)O.C1(=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1)C1=CC=CC=C1 XWKFJNWYADOUCL-UHFFFAOYSA-N 0.000 description 1
NNUIKTKILISLEC-UHFFFAOYSA-N C(C)(=O)O.C1(=CC=CC=C1)C1=CC=C(C(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C=C1 Chemical compound C(C)(=O)O.C1(=CC=CC=C1)C1=CC=C(C(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C=C1 NNUIKTKILISLEC-UHFFFAOYSA-N 0.000 description 1
JZMUHBAVSWHUAP-UHFFFAOYSA-N C(C)(=O)O.C1(=CC=CC=C1)C=CS(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.C1(=CC=CC=C1)C=CS(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 JZMUHBAVSWHUAP-UHFFFAOYSA-N 0.000 description 1
LHMLHITZUGKTPP-UHFFFAOYSA-N C(C)(=O)O.C1(=CC=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.C1(=CC=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 LHMLHITZUGKTPP-UHFFFAOYSA-N 0.000 description 1
KVQOIUQVPSMWPX-UHFFFAOYSA-N C(C)(=O)O.C1=C(C=CC2=CC=CC=C12)CN1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.C1=C(C=CC2=CC=CC=C12)CN1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 KVQOIUQVPSMWPX-UHFFFAOYSA-N 0.000 description 1
OETGWRRCCLJSDG-UHFFFAOYSA-N C(C)(=O)O.C1=C(C=CC2=CC=CC=C12)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 Chemical compound C(C)(=O)O.C1=C(C=CC2=CC=CC=C12)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 OETGWRRCCLJSDG-UHFFFAOYSA-N 0.000 description 1
JMYRJYRBNLMPGX-UHFFFAOYSA-N C(C)(=O)O.C1=C(C=CC=2OC3=C(C21)C=CC=C3)S(=O)(=O)N3CCN(CC3)C(=O)C3=CC=C(C(=N)N)C=C3 Chemical compound C(C)(=O)O.C1=C(C=CC=2OC3=C(C21)C=CC=C3)S(=O)(=O)N3CCN(CC3)C(=O)C3=CC=C(C(=N)N)C=C3 JMYRJYRBNLMPGX-UHFFFAOYSA-N 0.000 description 1
VEDIWVMUSUSBNU-UHFFFAOYSA-N C(C)(=O)O.CN(C1=C2C=CC=C(C2=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C Chemical compound C(C)(=O)O.CN(C1=C2C=CC=C(C2=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C VEDIWVMUSUSBNU-UHFFFAOYSA-N 0.000 description 1
ZNMRIHOSYXORMZ-UHFFFAOYSA-N C(C)(=O)O.COC(=O)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.COC(=O)C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 ZNMRIHOSYXORMZ-UHFFFAOYSA-N 0.000 description 1
NBUKRMPVNQMBKB-UHFFFAOYSA-N C(C)(=O)O.COC1=C(C=C(C=C1)C)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.COC1=C(C=C(C=C1)C)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 NBUKRMPVNQMBKB-UHFFFAOYSA-N 0.000 description 1
KVMNRVNTSVYIHE-UHFFFAOYSA-N C(C)(=O)O.COC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.COC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 KVMNRVNTSVYIHE-UHFFFAOYSA-N 0.000 description 1
PILGXBMOAHYQLD-UHFFFAOYSA-N C(C)(=O)O.CS(=O)(=O)C1=C(C=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.CS(=O)(=O)C1=C(C=CC=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 PILGXBMOAHYQLD-UHFFFAOYSA-N 0.000 description 1
MENGGCOOSRZKQT-UHFFFAOYSA-N C(C)(=O)O.CS(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.CS(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 MENGGCOOSRZKQT-UHFFFAOYSA-N 0.000 description 1
AOMRNZJHKWMCQQ-UHFFFAOYSA-N C(C)(=O)O.ClC1=C(C(=CC(=C1)Cl)Cl)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 Chemical compound C(C)(=O)O.ClC1=C(C(=CC(=C1)Cl)Cl)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 AOMRNZJHKWMCQQ-UHFFFAOYSA-N 0.000 description 1
NSHPIPNPVAYEKL-UHFFFAOYSA-N C(C)(=O)O.ClC1=C(C(=CC(=C1)Cl)OC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.ClC1=C(C(=CC(=C1)Cl)OC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 NSHPIPNPVAYEKL-UHFFFAOYSA-N 0.000 description 1
LOGMNWYABGSYCG-UHFFFAOYSA-N C(C)(=O)O.ClC1=C(C=CC=C1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.ClC1=C(C=CC=C1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 LOGMNWYABGSYCG-UHFFFAOYSA-N 0.000 description 1
BDSUYCRRIWETKN-UHFFFAOYSA-N C(C)(=O)O.ClC1=CC(=C(C=C1C)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C Chemical compound C(C)(=O)O.ClC1=CC(=C(C=C1C)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)C BDSUYCRRIWETKN-UHFFFAOYSA-N 0.000 description 1
ZAYWKYKCNWYDPS-UHFFFAOYSA-N C(C)(=O)O.ClC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 Chemical compound C(C)(=O)O.ClC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 ZAYWKYKCNWYDPS-UHFFFAOYSA-N 0.000 description 1
WHGMXADIHAYEMH-UHFFFAOYSA-N C(C)(=O)O.ClC=1C=C(C(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C=CC1Cl Chemical compound C(C)(=O)O.ClC=1C=C(C(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C=CC1Cl WHGMXADIHAYEMH-UHFFFAOYSA-N 0.000 description 1
MNKQVKAZCZYMMT-UHFFFAOYSA-N C(C)(=O)O.ClC=1C=C(C=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.ClC=1C=C(C=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 MNKQVKAZCZYMMT-UHFFFAOYSA-N 0.000 description 1
DTQXFGAPINFFQH-UHFFFAOYSA-N C(C)(=O)O.ClC=1C=C(C=CC1C)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.ClC=1C=C(C=CC1C)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 DTQXFGAPINFFQH-UHFFFAOYSA-N 0.000 description 1
ZTYHTZVVNHMXRF-UHFFFAOYSA-N C(C)(=O)O.ClC=1C=C(C=CC1C)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 Chemical compound C(C)(=O)O.ClC=1C=C(C=CC1C)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 ZTYHTZVVNHMXRF-UHFFFAOYSA-N 0.000 description 1
AXPSHHMBKJUKIQ-UHFFFAOYSA-N C(C)(=O)O.ClC=1C=C(C=CC1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.ClC=1C=C(C=CC1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 AXPSHHMBKJUKIQ-UHFFFAOYSA-N 0.000 description 1
RXNNGPMKPJTLLG-UHFFFAOYSA-N C(C)(=O)O.ClC=1C=C2C=CC(=CC2=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.ClC=1C=C2C=CC(=CC2=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 RXNNGPMKPJTLLG-UHFFFAOYSA-N 0.000 description 1
AGTOIZRESORIDV-UHFFFAOYSA-N C(C)(=O)O.FC(C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)(F)F Chemical compound C(C)(=O)O.FC(C1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1)(F)F AGTOIZRESORIDV-UHFFFAOYSA-N 0.000 description 1
UGJSMFCPLDDBMY-UHFFFAOYSA-N C(C)(=O)O.FC(C=1C=C(C=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1)(F)F Chemical compound C(C)(=O)O.FC(C=1C=C(C=CC1)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1)(F)F UGJSMFCPLDDBMY-UHFFFAOYSA-N 0.000 description 1
XOHDGLZAIKDGOX-UHFFFAOYSA-N C(C)(=O)O.FC(OC1=CC=C(C(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C=C1)(F)F Chemical compound C(C)(=O)O.FC(OC1=CC=C(C(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C=C1)(F)F XOHDGLZAIKDGOX-UHFFFAOYSA-N 0.000 description 1
DQPOUQJBZVUYJS-UHFFFAOYSA-N C(C)(=O)O.FC=1C=C(C=CC1OC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.FC=1C=C(C=CC1OC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 DQPOUQJBZVUYJS-UHFFFAOYSA-N 0.000 description 1
XTYYTKNHDATGKT-UHFFFAOYSA-N C(C)(=O)O.NC1=C(C=CC(=C1)OC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.NC1=C(C=CC(=C1)OC)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 XTYYTKNHDATGKT-UHFFFAOYSA-N 0.000 description 1
QLHJMNGLTYQDPV-UHFFFAOYSA-N C(C)(=O)O.NC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.NC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 QLHJMNGLTYQDPV-UHFFFAOYSA-N 0.000 description 1
LQUABFIAOKHCBE-UHFFFAOYSA-N C(C)(=O)O.NC=1C=C(C=CC1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.NC=1C=C(C=CC1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 LQUABFIAOKHCBE-UHFFFAOYSA-N 0.000 description 1
CVYLGBRQAWNNJZ-UHFFFAOYSA-N C(C)(=O)O.NC=1C=C(C=CC1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 Chemical compound C(C)(=O)O.NC=1C=C(C=CC1Cl)S(=O)(=O)N1CCN(CC1)C(=O)C=1C=C(C(=N)N)C=CC1 CVYLGBRQAWNNJZ-UHFFFAOYSA-N 0.000 description 1
ASGSXGPVUBOMPO-UHFFFAOYSA-N C(C)(=O)O.NC=1C=C(CS(=O)(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C(=CC1)C Chemical compound C(C)(=O)O.NC=1C=C(CS(=O)(=O)N2CCN(CC2)C(=O)C2=CC=C(C(=N)N)C=C2)C(=CC1)C ASGSXGPVUBOMPO-UHFFFAOYSA-N 0.000 description 1
VNBRZBUVVVSBTL-UHFFFAOYSA-N C(C)(=O)O.O(C1=CC=CC=C1)CC(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 Chemical compound C(C)(=O)O.O(C1=CC=CC=C1)CC(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1 VNBRZBUVVVSBTL-UHFFFAOYSA-N 0.000 description 1
RDTDCJGWDKPKOM-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C RDTDCJGWDKPKOM-UHFFFAOYSA-N 0.000 description 1
XHVYPDCCLCDOOB-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C(C)C Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C(C)C XHVYPDCCLCDOOB-UHFFFAOYSA-N 0.000 description 1
PSRAJMRRTJAZEK-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=C(C=C(C=C1)Cl)Cl Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=C(C=C(C=C1)Cl)Cl PSRAJMRRTJAZEK-UHFFFAOYSA-N 0.000 description 1
NGYTVPUNXIDXTH-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC(=C(C=C1)OC)OC Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC(=C(C=C1)OC)OC NGYTVPUNXIDXTH-UHFFFAOYSA-N 0.000 description 1
LEGWCEOVHZYOPS-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=CC2=CC=CC=C12 Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=CC2=CC=CC=C12 LEGWCEOVHZYOPS-UHFFFAOYSA-N 0.000 description 1
YIYKZZAIXOMVJM-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=CC=C1 Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=CC=C1 YIYKZZAIXOMVJM-UHFFFAOYSA-N 0.000 description 1
RQLKEAHTORTVGI-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C=CC1=CC=CC=C1 Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C=CC1=CC=CC=C1 RQLKEAHTORTVGI-UHFFFAOYSA-N 0.000 description 1
RNBZSQUZGNWTQS-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)CC1=CC=CC=C1 Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)CC1=CC=CC=C1 RNBZSQUZGNWTQS-UHFFFAOYSA-N 0.000 description 1
ADWVASLPGHSXJF-UHFFFAOYSA-N C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)CCCCCCCCCC Chemical compound C(C)(=O)O.O=C(CC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)CCCCCCCCCC ADWVASLPGHSXJF-UHFFFAOYSA-N 0.000 description 1
LYICCZRDXUTZPC-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC(=C(C=C1)C)Cl Chemical compound C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC(=C(C=C1)C)Cl LYICCZRDXUTZPC-UHFFFAOYSA-N 0.000 description 1
CNBMJFYJBGFADH-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1 Chemical compound C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1 CNBMJFYJBGFADH-UHFFFAOYSA-N 0.000 description 1
AUPSOCAGQZINKN-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1 Chemical compound C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1 AUPSOCAGQZINKN-UHFFFAOYSA-N 0.000 description 1
YBMAOOGTWHOINC-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)CCC Chemical compound C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)CCC YBMAOOGTWHOINC-UHFFFAOYSA-N 0.000 description 1
OHVLEXDHZPHVSI-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)Cl Chemical compound C(C)(=O)O.O=C(CCC1=CC=C(C(=N)N)C=C1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)Cl OHVLEXDHZPHVSI-UHFFFAOYSA-N 0.000 description 1
TZHOHBFNHHQJBP-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=C(C=C(C=C1C)C)C Chemical compound C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=C(C=C(C=C1C)C)C TZHOHBFNHHQJBP-UHFFFAOYSA-N 0.000 description 1
HZJCSBJONUGUGF-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=CC(=C(C=C1)C)Cl Chemical compound C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=CC(=C(C=C1)C)Cl HZJCSBJONUGUGF-UHFFFAOYSA-N 0.000 description 1
MNBPKURIKQACDO-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1 Chemical compound C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=CC2=CC=CC=C2C=C1 MNBPKURIKQACDO-UHFFFAOYSA-N 0.000 description 1
NPPCPWDYIWKDQY-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1 Chemical compound C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)C1=CC=C(C=C1)C1=CC=CC=C1 NPPCPWDYIWKDQY-UHFFFAOYSA-N 0.000 description 1
XOYXTDQYNLLENX-UHFFFAOYSA-N C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)CCCC Chemical compound C(C)(=O)O.O=C(CCC=1C=C(C(=N)N)C=CC1)N1CCN(CC1)S(=O)(=O)CCCC XOYXTDQYNLLENX-UHFFFAOYSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229920002284 Cellulose triacetate Polymers 0.000 description 1
VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
ARGABROETYHEBZ-UHFFFAOYSA-N ClC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1.C(C)(=O)O Chemical compound ClC1=CC=C(C=C1)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C(=N)N)C=C1.C(C)(=O)O ARGABROETYHEBZ-UHFFFAOYSA-N 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
101100134925 Gallus gallus COR6 gene Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
SFWMNPRILVLLNF-UHFFFAOYSA-N N1=CC=CC2=CC=CC(=C12)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C=C1)C1=NOC(=N1)C Chemical compound N1=CC=CC2=CC=CC(=C12)S(=O)(=O)N1CCN(CC1)C(=O)C1=CC=C(C=C1)C1=NOC(=N1)C SFWMNPRILVLLNF-UHFFFAOYSA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
239000004264 Petrolatum Substances 0.000 description 1
YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
VHQJTTAVWWDHAD-UHFFFAOYSA-N [4-(1,3-benzodioxole-5-carbonyl)piperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)C=2C=C3OCOC3=CC=2)=N1 VHQJTTAVWWDHAD-UHFFFAOYSA-N 0.000 description 1
JKBFFERUQAUXNB-UHFFFAOYSA-N [4-(2,3-dichlorophenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C(=C(Cl)C=CC=2)Cl)=N1 JKBFFERUQAUXNB-UHFFFAOYSA-N 0.000 description 1
PGKLSNFBPJPTMB-UHFFFAOYSA-N [4-(2,5-dichlorophenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C(=CC=C(Cl)C=2)Cl)=N1 PGKLSNFBPJPTMB-UHFFFAOYSA-N 0.000 description 1
OYKWAIATSNZTJE-UHFFFAOYSA-N [4-(2-methoxy-5-methylphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 OYKWAIATSNZTJE-UHFFFAOYSA-N 0.000 description 1
QFMUUJFFFWEIJD-UHFFFAOYSA-N [4-(3,4-dichlorobenzoyl)piperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)C=2C=C(Cl)C(Cl)=CC=2)=N1 QFMUUJFFFWEIJD-UHFFFAOYSA-N 0.000 description 1
KBZTYOHTHDNCSV-UHFFFAOYSA-N [4-(3,4-difluorophenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=C(F)C(F)=CC=2)=N1 KBZTYOHTHDNCSV-UHFFFAOYSA-N 0.000 description 1
MCNONBNDNHLDEY-UHFFFAOYSA-N [4-(3,4-dimethoxyphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound C1=C(OC)C(OC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 MCNONBNDNHLDEY-UHFFFAOYSA-N 0.000 description 1
YELKRDFCPLHMQI-UHFFFAOYSA-N [4-(3-chloro-4-methylphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=C(Cl)C(C)=CC=2)=N1 YELKRDFCPLHMQI-UHFFFAOYSA-N 0.000 description 1
XTJTZVKREUJUDI-UHFFFAOYSA-N [4-(4-bromo-2-ethylphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound CCC1=CC(Br)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 XTJTZVKREUJUDI-UHFFFAOYSA-N 0.000 description 1
WBQSBRNWBIQIAQ-UHFFFAOYSA-N [4-(4-butylphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound C1=CC(CCCC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 WBQSBRNWBIQIAQ-UHFFFAOYSA-N 0.000 description 1
JKRGDGNBDSMWHY-UHFFFAOYSA-N [4-(4-chloro-2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C(=CC(Cl)=C(C)C=2)C)=N1 JKRGDGNBDSMWHY-UHFFFAOYSA-N 0.000 description 1
GHBIVKJXUIQVBN-UHFFFAOYSA-N [4-(4-chlorophenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=CC(Cl)=CC=2)=N1 GHBIVKJXUIQVBN-UHFFFAOYSA-N 0.000 description 1
HATHMWNDSDOWJJ-UHFFFAOYSA-N [4-(4-ethylphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound C1=CC(CC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 HATHMWNDSDOWJJ-UHFFFAOYSA-N 0.000 description 1
REIFGYORSIPRLU-UHFFFAOYSA-N [4-(4-methoxy-2-nitrophenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 REIFGYORSIPRLU-UHFFFAOYSA-N 0.000 description 1
QBSLINCUEUPGMO-UHFFFAOYSA-N [4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 QBSLINCUEUPGMO-UHFFFAOYSA-N 0.000 description 1
BKFSMJDURCVBJG-UHFFFAOYSA-N [4-(5-chloro-1,3-dimethylpyrazol-4-yl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C2=C(N(C)N=C2C)Cl)=N1 BKFSMJDURCVBJG-UHFFFAOYSA-N 0.000 description 1
NIYRWTYHYGEGFI-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-(4-methylsulfonylpiperazin-1-yl)methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(C)(=O)=O)=N1 NIYRWTYHYGEGFI-UHFFFAOYSA-N 0.000 description 1
PHTRJLHWRPLIIF-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-(4-naphthalen-1-ylsulfonylpiperazin-1-yl)methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C3=CC=CC=C3C=CC=2)=N1 PHTRJLHWRPLIIF-UHFFFAOYSA-N 0.000 description 1
FEONFIDAWBBDCR-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=C3C=CC=CC3=CC=2)=N1 FEONFIDAWBBDCR-UHFFFAOYSA-N 0.000 description 1
ZDKIMNCHMGDTQF-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-(4-propan-2-ylsulfonylpiperazin-1-yl)methanone Chemical compound C1CN(S(=O)(=O)C(C)C)CCN1C(=O)C1=CC=C(C=2N=C(C)ON=2)C=C1 ZDKIMNCHMGDTQF-UHFFFAOYSA-N 0.000 description 1
DHJVUXNUVYCHSL-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-(4-thiophen-2-ylsulfonylpiperazin-1-yl)methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2SC=CC=2)=N1 DHJVUXNUVYCHSL-UHFFFAOYSA-N 0.000 description 1
CKCWUCLMXJLTHJ-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-(3-nitrobenzoyl)piperazin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)C=2C=C(C=CC=2)[N+]([O-])=O)=N1 CKCWUCLMXJLTHJ-UHFFFAOYSA-N 0.000 description 1
IIIGILACKIYQCL-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=CC(C)=CC=2)=N1 IIIGILACKIYQCL-UHFFFAOYSA-N 0.000 description 1
OVTIWMXHZVONMZ-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-(4-nitrophenyl)sulfonylpiperazin-1-yl]methanone;4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1.O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=N1 OVTIWMXHZVONMZ-UHFFFAOYSA-N 0.000 description 1
GFJNXIZHMVBQJM-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-(4-phenylphenyl)sulfonylpiperazin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)=N1 GFJNXIZHMVBQJM-UHFFFAOYSA-N 0.000 description 1
CCMNIRNOSXYSJK-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-(4-propylphenyl)sulfonylpiperazin-1-yl]methanone Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 CCMNIRNOSXYSJK-UHFFFAOYSA-N 0.000 description 1
CYYKSELDONEETL-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-(pyridine-3-carbonyl)piperazin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)C=2C=NC=CC=2)=N1 CYYKSELDONEETL-UHFFFAOYSA-N 0.000 description 1
DZTCQPVLGQWNPH-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-[(2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-yl)sulfonyl]piperazin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C(=C3CCC(C)(C)OC3=C(C)C=2C)C)=N1 DZTCQPVLGQWNPH-UHFFFAOYSA-N 0.000 description 1
HXJDAPRGZRUFRI-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-[4-[4-(trifluoromethoxy)benzoyl]piperazin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)C=2C=CC(OC(F)(F)F)=CC=2)=N1 HXJDAPRGZRUFRI-UHFFFAOYSA-N 0.000 description 1
KHQGLPBVNJZDRO-UHFFFAOYSA-N [4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-piperazin-1-ylmethanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCNCC2)=N1 KHQGLPBVNJZDRO-UHFFFAOYSA-N 0.000 description 1
CWOLYRCVRHVJEF-UHFFFAOYSA-N [4-(6-chloronaphthalen-2-yl)sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)=N1 CWOLYRCVRHVJEF-UHFFFAOYSA-N 0.000 description 1
FXIUYYJFQKWNBV-UHFFFAOYSA-N [4-(benzenesulfonyl)piperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2C=CC=CC=2)=N1 FXIUYYJFQKWNBV-UHFFFAOYSA-N 0.000 description 1
NFAMCOWYHVQFAU-UHFFFAOYSA-N [4-[(2-methyl-5-nitrophenyl)methylsulfonyl]piperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)CC=2C(=CC=C(C=2)[N+]([O-])=O)C)=N1 NFAMCOWYHVQFAU-UHFFFAOYSA-N 0.000 description 1
IWYBLDWFULNRAO-UHFFFAOYSA-N [4-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]piperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C2=C(ON=C2C)C)=N1 IWYBLDWFULNRAO-UHFFFAOYSA-N 0.000 description 1
GKXDWJGMSOPCSV-UHFFFAOYSA-N [4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]-(4-phenylphenyl)methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)=N1 GKXDWJGMSOPCSV-UHFFFAOYSA-N 0.000 description 1
BTVKPWQEMSVRKZ-UHFFFAOYSA-N [4-[5-(dimethylamino)naphthalen-1-yl]sulfonylpiperazin-1-yl]-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanone Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)N(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=NOC(C)=N1 BTVKPWQEMSVRKZ-UHFFFAOYSA-N 0.000 description 1
BNFDHOKRSXZOIX-UHFFFAOYSA-N [4-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]piperazin-1-yl]-naphthalen-2-ylmethanone Chemical compound O1C(C)=NC(C=2C=CC(CN3CCN(CC3)C(=O)C=3C=C4C=CC=CC4=CC=3)=CC=2)=N1 BNFDHOKRSXZOIX-UHFFFAOYSA-N 0.000 description 1
IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
239000012346 acetyl chloride Substances 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
230000004913 activation Effects 0.000 description 1
150000001263 acyl chlorides Chemical class 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
125000002723 alicyclic group Chemical group 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
150000001342 alkaline earth metals Chemical class 0.000 description 1
125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
230000002429 anti-coagulating effect Effects 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
125000003435 aroyl group Chemical group 0.000 description 1
125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
125000005099 aryl alkyl carbonyl group Chemical group 0.000 description 1
125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
125000004391 aryl sulfonyl group Chemical group 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
229940092714 benzenesulfonic acid Drugs 0.000 description 1
PJHUABJTDFXYRQ-UHFFFAOYSA-N benzoyl azide Chemical compound [N-]=[N+]=NC(=O)C1=CC=CC=C1 PJHUABJTDFXYRQ-UHFFFAOYSA-N 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
150000003938 benzyl alcohols Chemical class 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 1
WEDIIKBPDQQQJU-UHFFFAOYSA-N butane-1-sulfonyl chloride Chemical compound CCCCS(Cl)(=O)=O WEDIIKBPDQQQJU-UHFFFAOYSA-N 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical class C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
125000001589 carboacyl group Chemical group 0.000 description 1
150000001719 carbohydrate derivatives Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
238000013375 chromatographic separation Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
238000004040 coloring Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
KQWGXHWJMSMDJJ-UHFFFAOYSA-N cyclohexyl isocyanate Chemical compound O=C=NC1CCCCC1 KQWGXHWJMSMDJJ-UHFFFAOYSA-N 0.000 description 1
WEPUZBYKXNKSDH-UHFFFAOYSA-N cyclopentanecarbonyl chloride Chemical compound ClC(=O)C1CCCC1 WEPUZBYKXNKSDH-UHFFFAOYSA-N 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
OBYFJZMEJNHFHC-UHFFFAOYSA-N cyclopentyl-[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]methanone Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)C2CCCC2)=N1 OBYFJZMEJNHFHC-UHFFFAOYSA-N 0.000 description 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
239000000890 drug combination Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 1
NUEYULKJUMENGF-UHFFFAOYSA-N ethyl 3-[[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine-1-carbonyl]amino]benzoate Chemical compound CCOC(=O)C1=CC=CC(NC(=O)N2CCN(CC2)C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)=C1 NUEYULKJUMENGF-UHFFFAOYSA-N 0.000 description 1
UPXGGIRFDZENRD-UHFFFAOYSA-N ethyl 3-isocyanatobenzoate Chemical compound CCOC(=O)C1=CC=CC(N=C=O)=C1 UPXGGIRFDZENRD-UHFFFAOYSA-N 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
238000001914 filtration Methods 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
235000013773 glyceryl triacetate Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
150000008282 halocarbons Chemical class 0.000 description 1
230000036541 health Effects 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
150000002391 heterocyclic compounds Chemical class 0.000 description 1
125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
150000002463 imidates Chemical class 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000013067 intermediate product Substances 0.000 description 1
125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
238000002955 isolation Methods 0.000 description 1
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 1
125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
FEAACKGLTFWWSJ-UHFFFAOYSA-N n-(4-carbamimidoylphenyl)-4-(2-phenylethenylsulfonyl)piperazine-1-carboxamide Chemical compound C1=CC(C(=N)N)=CC=C1NC(=O)N1CCN(S(=O)(=O)C=CC=2C=CC=CC=2)CC1 FEAACKGLTFWWSJ-UHFFFAOYSA-N 0.000 description 1
FUYDRTHBHUKTOE-UHFFFAOYSA-N n-(4-carbamimidoylphenyl)-4-(4-chlorophenyl)sulfonylpiperazine-1-carboxamide Chemical compound C1=CC(C(=N)N)=CC=C1NC(=O)N1CCN(S(=O)(=O)C=2C=CC(Cl)=CC=2)CC1 FUYDRTHBHUKTOE-UHFFFAOYSA-N 0.000 description 1
OGTCOBPMCVPAHG-UHFFFAOYSA-N n-(4-carbamimidoylphenyl)-4-(4-phenylphenyl)sulfonylpiperazine-1-carboxamide Chemical compound C1=CC(C(=N)N)=CC=C1NC(=O)N1CCN(S(=O)(=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)CC1 OGTCOBPMCVPAHG-UHFFFAOYSA-N 0.000 description 1
DECNNJZZCQVDDY-UHFFFAOYSA-N n-(4-carbamimidoylphenyl)-4-(4-propylphenyl)sulfonylpiperazine-1-carboxamide Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)NC=2C=CC(=CC=2)C(N)=N)CC1 DECNNJZZCQVDDY-UHFFFAOYSA-N 0.000 description 1
HAHJTWFTDKAYAZ-UHFFFAOYSA-N n-(4-carbamimidoylphenyl)-4-(6-chloronaphthalen-2-yl)sulfonylpiperazine-1-carboxamide Chemical compound C1=CC(C(=N)N)=CC=C1NC(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1 HAHJTWFTDKAYAZ-UHFFFAOYSA-N 0.000 description 1
SAHOYVSJLLBPNR-UHFFFAOYSA-N n-(4-carbamimidoylphenyl)-4-naphthalen-2-ylsulfonylpiperazine-1-carboxamide Chemical compound C1=CC(C(=N)N)=CC=C1NC(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC=CC3=CC=2)CC1 SAHOYVSJLLBPNR-UHFFFAOYSA-N 0.000 description 1
RCFONTIQFPGPOR-UHFFFAOYSA-N n-(4-methoxyphenyl)-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine-1-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 RCFONTIQFPGPOR-UHFFFAOYSA-N 0.000 description 1
NORXYXOCGGVFLK-UHFFFAOYSA-N n-[2-chloro-4-[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]sulfonylphenyl]acetamide Chemical compound C1=C(Cl)C(NC(=O)C)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 NORXYXOCGGVFLK-UHFFFAOYSA-N 0.000 description 1
MKPGKCKVTRZRAW-UHFFFAOYSA-N n-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-4-(2,4,6-trimethylphenyl)sulfonylpiperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(NC(=O)N3CCN(CC3)S(=O)(=O)C=3C(=CC(C)=CC=3C)C)=CC=2)=N1 MKPGKCKVTRZRAW-UHFFFAOYSA-N 0.000 description 1
ZOHVQLOAZQKPKL-UHFFFAOYSA-N n-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-4-(2-phenylethenylsulfonyl)piperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(NC(=O)N3CCN(CC3)S(=O)(=O)C=CC=3C=CC=CC=3)=CC=2)=N1 ZOHVQLOAZQKPKL-UHFFFAOYSA-N 0.000 description 1
AUXJXZXYKLAXSZ-UHFFFAOYSA-N n-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-4-(4-propylphenyl)sulfonylpiperazine-1-carboxamide Chemical compound C1=CC(CCC)=CC=C1S(=O)(=O)N1CCN(C(=O)NC=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 AUXJXZXYKLAXSZ-UHFFFAOYSA-N 0.000 description 1
TUOVBVUSWHDGKW-UHFFFAOYSA-N n-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-4-naphthalen-2-ylsulfonylpiperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(NC(=O)N3CCN(CC3)S(=O)(=O)C=3C=C4C=CC=CC4=CC=3)=CC=2)=N1 TUOVBVUSWHDGKW-UHFFFAOYSA-N 0.000 description 1
KQRGHLAZECBMIJ-UHFFFAOYSA-N n-[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]piperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(NC(=O)N3CCNCC3)=CC=2)=N1 KQRGHLAZECBMIJ-UHFFFAOYSA-N 0.000 description 1
BSOQKBUFLIEAMO-UHFFFAOYSA-N n-[4-[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]sulfonylphenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)(=O)N1CCN(C(=O)C=2C=CC(=CC=2)C=2N=C(C)ON=2)CC1 BSOQKBUFLIEAMO-UHFFFAOYSA-N 0.000 description 1
KBIQUUKYTGHPQB-UHFFFAOYSA-N n-[[5-[4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazin-1-yl]sulfonylthiophen-2-yl]methyl]benzamide Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)S(=O)(=O)C=2SC(CNC(=O)C=3C=CC=CC=3)=CC=2)=N1 KBIQUUKYTGHPQB-UHFFFAOYSA-N 0.000 description 1
WWCMDOJWDCFIIB-UHFFFAOYSA-N n-[amino-[4-[4-(6-chloronaphthalen-2-yl)sulfonylpiperazine-1-carbonyl]phenyl]methylidene]acetamide Chemical compound C1=CC(C(=N)NC(=O)C)=CC=C1C(=O)N1CCN(S(=O)(=O)C=2C=C3C=CC(Cl)=CC3=CC=2)CC1 WWCMDOJWDCFIIB-UHFFFAOYSA-N 0.000 description 1
HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 1
GYSPSKZMWKTTGJ-UHFFFAOYSA-N n-butyl-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine-1-carboxamide Chemical compound C1CN(C(=O)NCCCC)CCN1C(=O)C1=CC=C(C=2N=C(C)ON=2)C=C1 GYSPSKZMWKTTGJ-UHFFFAOYSA-N 0.000 description 1
LNVYUTKFKPIPGN-UHFFFAOYSA-N n-cyclohexyl-4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine-1-carboxamide Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)NC2CCCCC2)=N1 LNVYUTKFKPIPGN-UHFFFAOYSA-N 0.000 description 1
XNLBCXGRQWUJLU-UHFFFAOYSA-N naphthalene-2-carbonyl chloride Chemical compound C1=CC=CC2=CC(C(=O)Cl)=CC=C21 XNLBCXGRQWUJLU-UHFFFAOYSA-N 0.000 description 1
125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
150000002828 nitro derivatives Chemical class 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
229910000069 nitrogen hydride Inorganic materials 0.000 description 1
LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
229910000510 noble metal Inorganic materials 0.000 description 1
125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
235000019271 petrolatum Nutrition 0.000 description 1
229940066842 petrolatum Drugs 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
229940049953 phenylacetate Drugs 0.000 description 1
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
150000003016 phosphoric acids Chemical class 0.000 description 1
OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
238000000746 purification Methods 0.000 description 1
125000003373 pyrazinyl group Chemical group 0.000 description 1
125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
125000004943 pyrimidin-6-yl group Chemical group N1=CN=CC=C1* 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
JUYUYCIJACTHMK-UHFFFAOYSA-N quinoline-8-sulfonyl chloride Chemical compound C1=CN=C2C(S(=O)(=O)Cl)=CC=CC2=C1 JUYUYCIJACTHMK-UHFFFAOYSA-N 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000006462 rearrangement reaction Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000000926 separation method Methods 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
239000012453 solvate Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
238000003797 solvolysis reaction Methods 0.000 description 1
239000008347 soybean phospholipid Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
125000000547 substituted alkyl group Chemical group 0.000 description 1
125000003107 substituted aryl group Chemical group 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 1
ZAECAOSXCPXBPI-UHFFFAOYSA-N tert-butyl 4-[(4-cyanophenyl)methyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC1=CC=C(C#N)C=C1 ZAECAOSXCPXBPI-UHFFFAOYSA-N 0.000 description 1
UIVQQOGNLTZXHZ-UHFFFAOYSA-N tert-butyl 4-[4-(5-methyl-1,2,4-oxadiazol-3-yl)benzoyl]piperazine-1-carboxylate Chemical compound O1C(C)=NC(C=2C=CC(=CC=2)C(=O)N2CCN(CC2)C(=O)OC(C)(C)C)=N1 UIVQQOGNLTZXHZ-UHFFFAOYSA-N 0.000 description 1
KKUJDIZFXGMVNW-UHFFFAOYSA-N tert-butyl 4-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl]piperazine-1-carboxylate Chemical compound O1C(C)=NC(C=2C=CC(NC(=O)N3CCN(CC3)C(=O)OC(C)(C)C)=CC=2)=N1 KKUJDIZFXGMVNW-UHFFFAOYSA-N 0.000 description 1
XUPZTLJRVSSAHE-UHFFFAOYSA-N tert-butyl 4-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methyl]piperazine-1-carboxylate Chemical compound O1C(C)=NC(C=2C=CC(CN3CCN(CC3)C(=O)OC(C)(C)C)=CC=2)=N1 XUPZTLJRVSSAHE-UHFFFAOYSA-N 0.000 description 1
VNNLHYZDXIBHKZ-UHFFFAOYSA-N thiophene-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CS1 VNNLHYZDXIBHKZ-UHFFFAOYSA-N 0.000 description 1
125000005425 toluyl group Chemical group 0.000 description 1
229960002622 triacetin Drugs 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229940099259 vaseline Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000008096 xylene Substances 0.000 description 1
229910052727 yttrium Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Quinoline Compounds (AREA)
Furan Compounds (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20001687A 1997-10-01 2000-03-31 Benzamidinderivater som faktor Xa-inhibitorer NO20001687L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19743435A DE19743435A1 (de)	1997-10-01	1997-10-01	Benzamidinderivate
PCT/EP1998/005898 WO1999016751A1 (fr)	1997-10-01	1998-09-16	DERIVES DE BENZAMIDINE UTILISES COMME INHIBITEURS DU FACTEUR Xa

Publications (2)

Publication Number	Publication Date
NO20001687D0 NO20001687D0 (no)	2000-03-31
NO20001687L true NO20001687L (no)	2000-03-31

Family

ID=7844313

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001687A NO20001687L (no)	1997-10-01	2000-03-31	Benzamidinderivater som faktor Xa-inhibitorer

Country Status (19)

Country	Link
US (1)	US6492368B1 (fr)
EP (1)	EP1025086B1 (fr)
JP (1)	JP2001518467A (fr)
KR (1)	KR20010024386A (fr)
CN (1)	CN1272107A (fr)
AR (1)	AR017164A1 (fr)
AT (1)	ATE243681T1 (fr)
AU (1)	AU736080B2 (fr)
BR (1)	BR9812699A (fr)
CA (1)	CA2305568A1 (fr)
DE (2)	DE19743435A1 (fr)
HU (1)	HUP0004306A3 (fr)
ID (1)	ID24430A (fr)
NO (1)	NO20001687L (fr)
PL (1)	PL339173A1 (fr)
RU (1)	RU2194044C2 (fr)
SK (1)	SK282799B6 (fr)
WO (1)	WO1999016751A1 (fr)
ZA (1)	ZA988937B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010015639A (ko) *	1997-09-30	2001-02-26	스즈키 다다시	술포닐 유도체
GB9809349D0 (en) *	1998-05-02	1998-07-01	Zeneca Ltd	Heterocyclic derivatives
PL343706A1 (en) *	1998-05-02	2001-08-27	Astrazeneca Ab	Heterocyclic derivatives which inhibit factor xa
US6747023B1 (en) *	1998-08-11	2004-06-08	Daiichi Pharmaceutical Co., Ltd.	Sulfonyl derivatives
EP1088821A1 (fr) *	1999-09-28	2001-04-04	Applied Research Systems ARS Holding N.V.	Derives des sulfamides pharmaceutiquement actifs
EP1829535A3 (fr) *	1999-10-27	2007-10-24	Tanox, Inc.	Antagonistes de facteur de tissus et leurs procédés d'utilisation
KR20070049251A (ko) *	1999-10-27	2007-05-10	타녹스 인코퍼레이티드	조직 인자 길항제 및 그의 사용 방법
DE10035928A1 (de)	2000-07-21	2002-03-07	Asta Medica Ag	Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035927A1 (de)	2000-07-21	2002-03-07	Asta Medica Ag	Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
EP1193256A1 (fr) *	2000-09-27	2002-04-03	Applied Research Systems ARS Holding N.V.	Derivés de benzénesulphonamide pharmaceutiquemant actifs comme inhibiteurs de protéines JNK
EP1193268A1 (fr) *	2000-09-27	2002-04-03	Applied Research Systems ARS Holding N.V.	Dérivés de sulfonamide pharmaceutiquement actifs comportant des groupes lipophiles ainsi que ionisables comme inhibiteurs de protéine junkinases
EP1193267A1 (fr) *	2000-09-27	2002-04-03	Applied Research Systems ARS Holding N.V.	Composés de sulfonamides hydrophiles pharmaceutiquement actifs
WO2002036587A2 (fr)	2000-11-01	2002-05-10	Cor Therapeutics, Inc.	Composes heterocycliques azotes et procede de fabrication de ces composes et de leurs intermediaires
DE10102322A1 (de)	2001-01-19	2002-07-25	Merck Patent Gmbh	Phenylderivate
DE10130718A1 (de) *	2001-06-26	2003-01-02	Merck Patent Gmbh	Kohlenhydratderivate
BR0307575A (pt)	2002-03-13	2004-12-21	Janssen Pharmaceutica Nv	Derivados de sulfonila como inibidores de histona desacetilase
DE60333260D1 (en)	2002-03-13	2010-08-19	Janssen Pharmaceutica Nv	Histone-deacetylase-inhibitoren
EP2982668A3 (fr)	2002-12-03	2016-04-13	Pharmacyclics LLC	Dérivés de 2-(2-hydroxybiphényl-3-yl)-1h-benzoimidazole-5-carboxamidine en tant qu'inhibiteurs du facteur viia inhibitors pour le traitement de maladies thromboemboliques
RU2337099C2 (ru) *	2003-04-03	2008-10-27	Мерк Патент Гмбх	Карбонильные соединения
DE10336716A1 (de) *	2003-08-11	2005-03-10	Merck Patent Gmbh	Verfahren zur Herstellung von N-Aryl-morpholinonen
KR101106652B1 (ko) *	2004-10-14	2012-01-18	빌렉스 아게	침전, 염의 재결정화 및 아로마틱 술폰산에 의한3-하이드록시아미디노페닐알라닌 유도체 정제 방법
TW200633990A (en)	2004-11-18	2006-10-01	Takeda Pharmaceuticals Co	Amide compound
RU2423349C2 (ru)	2004-12-24	2011-07-10	Астразенека Аб	Гетероциклические соединения в качестве антагонистов ccr2b
WO2007007588A1 (fr) *	2005-07-08	2007-01-18	Ono Pharmaceutical Co., Ltd.	Compose comportant un groupe cyclique ayant un noyau plan
AU2006326540A1 (en) *	2005-12-14	2007-06-21	Amgen Inc.	Diaza heterocyclic sulfonamide derivatives and their uses
GB0525957D0 (en)	2005-12-21	2006-02-01	Astrazeneca Ab	Methods
DE102005061624A1 (de) *	2005-12-21	2007-06-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
US7750012B2 (en)	2005-12-21	2010-07-06	Decode Genetics Ehf	Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation
HUE031972T2 (en)	2005-12-29	2017-08-28	Celtaxsys Inc	Diamine derivatives as inhibitors of leukotriene a4 hydrolase
WO2008019139A2 (fr)	2006-08-04	2008-02-14	Beth Israel Deaconess Medical Center	Inhibiteurs de la pyruvate kinase et procédés de traitement de maladie
CA2687754C (fr)	2007-06-08	2015-12-08	Janssen Pharmaceutica N.V.	Derives de piperidine/piperazine pour utilisation en tant qu'inhibiteurs de dgat
JO2972B1 (en)	2007-06-08	2016-03-15	جانسين فارماسوتيكا ان. في	Piperidine / piperazine derivatives
CA2687918C (fr) *	2007-06-08	2016-11-08	Janssen Pharmaceutica N.V.	Derives de piperidine/piperazine
WO2008148840A1 (fr)	2007-06-08	2008-12-11	Janssen Pharmaceutica N.V.	Dérivés de piperidine/piperazine
EP2182809B1 (fr)	2007-08-27	2018-01-17	Dart Neuroscience (Cayman) Ltd	Composés isoxazole thérapeutiques
SI2197841T1 (sl) *	2007-09-07	2012-02-29	Theravance Inc	Spojine, ki vsebujejo gvanidin, uporabne kot antagonisti muskarinskih receptorjev
EP2204368B1 (fr) *	2007-09-21	2014-05-21	Msd K.K.	Dérivés de 4-sulfonylpipéridine
PE20100083A1 (es)	2008-06-05	2010-02-17	Janssen Pharmaceutica Nv	Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
US20100152197A1 (en) *	2008-12-15	2010-06-17	Astrazeneca Ab	(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
EP2400968B1 (fr)	2009-02-26	2016-09-28	Reviva Pharmaceuticals, Inc.	Composition, synthèses et procédés d'utilisation des dérivés d'arylpipérazine
EP2417123A2 (fr)	2009-04-06	2012-02-15	Agios Pharmaceuticals, Inc.	Compositions thérapeutiques et procédés d'utilisation associés
CA2944788C (fr)	2009-06-29	2023-08-22	Agios Pharmaceuticals, Inc.	Composes, et compositions associees, qui modulent la pyruvate kinase m2, et methodes de fabrication associees
DK2448581T3 (en) *	2009-06-29	2017-03-13	Agios Pharmaceuticals Inc	Therapeutic compositions and methods for their applications
EP2651898B1 (fr)	2010-12-17	2015-12-09	Agios Pharmaceuticals, Inc.	Nouveaux dérivés de n-(4-(azétidine- 1 - carbonyl) phényl)-(hétéro-) arylsulfonamide en tant que modulateurs de la pyruvate kinase m2 (pmk2)
JP6092118B2 (ja)	2010-12-21	2017-03-08	アジオスファーマシューティカルズ，インコーポレイテッド	ニ環式ｐｋｍ２活性化剤
TWI549947B (zh)	2010-12-29	2016-09-21	阿吉歐斯製藥公司	治療化合物及組成物
PL3406251T3 (pl)	2011-05-03	2024-04-29	Agios Pharmaceuticals, Inc.	Aktywatory kinazy pirogronianowej do stosowania w terapii
WO2012151440A1 (fr)	2011-05-03	2012-11-08	Agios Pharmaceuticals, Inc.	Procédés d'utilisation d'activateurs de pyruvate kinase
FR2976943B1 (fr) *	2011-06-23	2013-07-12	Metabolys	Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
CU24341B1 (es)	2013-03-13	2018-05-08	Forma Therapeutics Inc	Compuestos y composiciones orgánicas inhibidores del ácido graso sintetasa (fasn) útiles para el tratamiento del cáncer, infecciones virales, obesidad y diabetes
BR112015022226A2 (pt) *	2013-03-14	2017-07-18	Celtaxsys Inc	inibidores de leucotrieno a4 hidrolase
WO2014139144A1 (fr)	2013-03-15	2014-09-18	Agios Pharmaceuticals, Inc.	Composés et compositions thérapeutiques
US9809552B2 (en)	2013-03-21	2017-11-07	Merck Patent Gmbh	Piperazine derivatives as FASN inhibitors
US11234976B2 (en)	2015-06-11	2022-02-01	Agios Pharmaceuticals, Inc.	Methods of using pyruvate kinase activators
TWI767148B (zh)	2018-10-10	2022-06-11	美商弗瑪治療公司	抑制脂肪酸合成酶(fasn)
EP3873214A4 (fr)	2018-10-29	2022-07-13	Forma Therapeutics, Inc.	Formes solides de (4-(2-fluoro-4-(1-méthyl-1h-benzo[d]imidazol-5-yl)benzoyl)pipérazin-1-yl)(1-hydroxycyclopropyl)méthanone

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ233503A (en) *	1989-05-15	1991-06-25	Janssen Pharmaceutica Nv	Substituted (thio)morpholinyl and piperazinyl alkylphenol ethers
EP0511347A1 (fr) *	1990-11-15	1992-11-04	Pentapharm A.G.	Derives de la phenylalanine metasubstitues
ZA928276B (en)	1991-10-31	1993-05-06	Daiichi Seiyaku Co	Aromatic amidine derivates and salts thereof.
GB9208740D0 (en) *	1992-04-23	1992-06-10	Glaxo Group Ltd	Chemical compounds
DE4234295A1 (de) *	1992-10-12	1994-04-14	Thomae Gmbh Dr K	Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4302485A1 (de) *	1993-01-29	1994-08-04	Merck Patent Gmbh	Piperazinderivate
DE122005000053I2 (de)	1995-03-30	2008-01-17	Pfizer Prod Inc	Chinazolinderivate
WO1997002245A1 (fr) *	1995-07-06	1997-01-23	Japan Tobacco Inc.	Derives de benzamidoxime et leur utilisation a des fins medicinales
CA2197364A1 (fr) *	1996-02-15	1997-08-16	Toshikazu Suzuki	Compose phenolique et methode de preparation
DE69835430T2 (de) *	1997-05-30	2007-03-08	Takeda Pharmaceutical Co. Ltd.	Sulfonamidderivate, ihre herstellung und verwendung

1997
- 1997-10-01 DE DE19743435A patent/DE19743435A1/de not_active Withdrawn
1998
- 1998-09-16 BR BR9812699-7A patent/BR9812699A/pt not_active IP Right Cessation
- 1998-09-16 HU HU0004306A patent/HUP0004306A3/hu unknown
- 1998-09-16 US US09/509,729 patent/US6492368B1/en not_active Expired - Fee Related
- 1998-09-16 EP EP98948982A patent/EP1025086B1/fr not_active Expired - Lifetime
- 1998-09-16 ID IDW20000609A patent/ID24430A/id unknown
- 1998-09-16 JP JP2000513837A patent/JP2001518467A/ja active Pending
- 1998-09-16 CN CN98809650A patent/CN1272107A/zh active Pending
- 1998-09-16 CA CA002305568A patent/CA2305568A1/fr not_active Abandoned
- 1998-09-16 RU RU2000110737/04A patent/RU2194044C2/ru not_active IP Right Cessation
- 1998-09-16 WO PCT/EP1998/005898 patent/WO1999016751A1/fr not_active Application Discontinuation
- 1998-09-16 PL PL98339173A patent/PL339173A1/xx unknown
- 1998-09-16 SK SK447-2000A patent/SK282799B6/sk unknown
- 1998-09-16 KR KR1020007003536A patent/KR20010024386A/ko not_active Withdrawn
- 1998-09-16 AU AU95407/98A patent/AU736080B2/en not_active Ceased
- 1998-09-16 AT AT98948982T patent/ATE243681T1/de not_active IP Right Cessation
- 1998-09-16 DE DE59808842T patent/DE59808842D1/de not_active Expired - Fee Related
- 1998-09-29 AR ARP980104841A patent/AR017164A1/es not_active Application Discontinuation
- 1998-09-30 ZA ZA988937A patent/ZA988937B/xx unknown
2000
- 2000-03-31 NO NO20001687A patent/NO20001687L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU9540798A (en)	1999-04-23
PL339173A1 (en)	2000-12-04
EP1025086A1 (fr)	2000-08-09
US6492368B1 (en)	2002-12-10
AU736080B2 (en)	2001-07-26
JP2001518467A (ja)	2001-10-16
CA2305568A1 (fr)	1999-04-08
RU2194044C2 (ru)	2002-12-10
SK4472000A3 (en)	2000-11-07
ZA988937B (en)	1999-03-31
WO1999016751A1 (fr)	1999-04-08
AR017164A1 (es)	2001-08-22
DE19743435A1 (de)	1999-04-08
NO20001687D0 (no)	2000-03-31
CN1272107A (zh)	2000-11-01
KR20010024386A (ko)	2001-03-26
DE59808842D1 (de)	2003-07-31
HUP0004306A3 (en)	2001-12-28
ATE243681T1 (de)	2003-07-15
HUP0004306A2 (hu)	2001-11-28
SK282799B6 (sk)	2002-12-03
ID24430A (id)	2000-07-20
BR9812699A (pt)	2000-08-22
EP1025086B1 (fr)	2003-06-25

Legal Events

Date	Code	Title	Description
2003-07-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20001687L (no)	2000-03-31	Benzamidinderivater som faktor Xa-inhibitorer
SK8572000A3 (en)	2001-07-10	Benzamine derivatives
US20040038858A1 (en)	2004-02-26	Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours
JP4732757B2 (ja)	2011-07-27	カルボキサミド
CA2364908A1 (fr)	2000-09-08	Derives de pyrazol-3-one
AU2004205354B2 (en)	2009-12-10	Carboxamide derivatives and their use as factor Xa inhibitors
US7183277B2 (en)	2007-02-27	Carboxylic acid amides
MXPA00003094A (en)	2001-07-09	Benzamidine derivatives as factor xa inhibitors
CZ20001183A3 (cs)	2000-07-12	Derivát benzamidinu jako inhibitor faktoru XA, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje
CZ20002126A3 (cs)	2000-09-13	Řešení se týká nosného tělesa (1) pro uspořádání elektrických kontaktů, které obsahuje elektricky nevodivé základní těleso, ve kterémjsou uspořádány elektrické kontakty (3). Nosné těleso (1) má modulovou konstrukci, sestávající z jednotlivých samostatných prvků (2,4), které mohou být spolu vzájemně sestaveny a spojeny. Jednotlivé samostatné prvky (2,4) mohou nebo nemusejí být opatřeny kontakty (3).
NO20025740L (no)	2002-11-29	Karbaminsyreestere som inhibitorer for faktor Xa
US20030171579A1 (en)	2003-09-11	Urethane derivatives
JP2004505106A (ja)	2004-02-19	アセトアミド誘導体並びに凝固第Ｘａおよび第ＶＩＩａ因子の阻害剤としてのその使用